Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
10:13
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

BSH 2020 VIRTUAL

 

9-14 November 2020 Virtual Conference
FAQs
   
Discussion forum - BSH 2020 VIRTUAL
    Topic - Red Cell Disorders

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
Characteristics of menstruation in sickle cell disease patients attending a tertiary health care centre in Northern Nigeria  Aisha Abba 1      11/9/2020 12:01:00 PM  
Patient Preferences for the Treatment of Paroxysmal Nocturnal Hemoglobinuria: Results of a Patient Survey of Ravulizumab (ALXN1210) and Eculizumab in the UK  Colin Griffin 1      11/9/2020 12:01:00 PM  
Evaluation Of High Performance Liquid Chromatography Pattern And Prevalence Of Thalassemia Trait In Port Harcourt, Nigeria  Hannah Omunakwe 1      11/9/2020 12:01:00 PM  
Anaemia and its correlates in HAART-Nave patients in Port Harcourt, Nigeria  Hannah Omunakwe 1      11/9/2020 12:01:00 PM  
Haemoglobin Distribution Width is Low in Alcoholic Liver Disease  Graham Gibbs 1      11/9/2020 12:01:00 PM  
One-Year Efficacy and Safety from a Phase 3 Trial of Ravulizumab in Adult Patients with Paroxysmal Nocturnal Haemoglobinuria Receiving Prior Eculizumab Treatment  Colin Griffin 1      11/9/2020 12:01:00 PM  
Improving the Laboratory Diagnosis of Pyruvate Kinase Deficiency  Claire Laas 1      11/9/2020 12:01:00 PM  
Evaluating luspatercept responders in the phase 3, randomised, double-blind, placebo-controlled BELIEVE trial of luspatercept in adult beta-thalassaemia patients who require regular red blood cell transfusions  Annette Hay 1      11/9/2020 12:01:00 PM  
The Successful use of Eculizumab to Switch off Haemolysis in Aggressive warm IgM Autoimmune Haemolytic Anaemia: Case Report and Literature Review  Mohammed Altohami 1      11/9/2020 12:01:00 PM  
Association Between Protein C, Protein S and Cerebral Blood Flow Velocity in Sickle Cell Disease Patients with High Risk of Cerebrovascular Accident  Ebele Uche 1      11/9/2020 12:01:00 PM  
Unilateral Versus Bilateral Peripheral Access Using Ultrasound Machine Guidance in Patients Undergoing Red Blood Cell Exchange Transfusion: A Comparative Results  Romeo Valeza 1      11/9/2020 12:01:00 PM  
Effects of luspatercept on iron overload and impact on responders to luspatercept: results from the BELIEVE trial  Annette Hay 1      11/9/2020 12:01:00 PM  
Sickle Cell Disease Pain Management in the Emergency Department: a single centre experience  Jonathan Bennett 1      11/9/2020 12:01:00 PM  
Breakthrough Haemolysis in Adult Patients with Paroxysmal Nocturnal Haemoglobinuria Treated with Ravulizumab: Results of a 52-Week Extension from Two Phase 3 Studies.  Colin Griffin 1      11/9/2020 12:01:00 PM  
FREQUENCY OF ANEMIA AND CAUSES IN POST LIVER TRANSPLANT PATIENTS FROM TERTIARY CARE HOSPITAL IN PAKISTAN: A RETROSPECTIVE AUDIT  Samreen Khan 1      11/9/2020 12:01:00 PM  
One-Year Efficacy of Ravulizumab (ALXN1210) in Adult Patients with Paroxysmal Nocturnal Haemoglobinuria Naive to Complement Inhibitors  Colin Griffin 1      11/9/2020 12:01:00 PM  
Assessment of longer-term efficacy, safety, and haematological improvement in the phase 3, randomised, double-blind, placebo-controlled MEDALIST trial of luspatercept to treat anaemia in patients with lower-risk myelodysplastic syndromes with ring sideroblasts who require red blood cell transfusions  Annette Hay 1      11/9/2020 12:01:00 PM  
An Investigation into the presence of complement factors on erythrocyte vesicles in sickle cell disease  Chidinma Obieze 1      11/9/2020 12:01:00 PM  
Luspatercept significantly reduces red blood cell transfusion burden, regardless of gene mutation frequency, spectrum, and prognostic significance, among patients with lower-risk myelodysplastic syndromes enrolled in the MEDALIST trial  Annette Hay 1      11/9/2020 12:01:00 PM  
       




Most viewed poster for this congress
Poster: 1
Visits: 556
Title: Whole genome profiling of adult B-other acute lymphoblastic leukaemia on the UKALL14 trial
Authors: Daniel Leongamornlert , E. Barretta, S. Lee, T. Creasey, R. Mitchell, A. A. Kirkwood, L Clifton-Hadley, P. Patrick, P. Campbell, B. Patel, A. Moorman, A. K. Fielding, E. Papaemmanuil
Centre: 

Poster most viewed in this topic
Poster: 147
Visits: 107
Title: Assessment of longer-term efficacy, safety, and haematological improvement in the phase 3, randomised, double-blind, placebo-controlled MEDALIST trial of luspatercept to treat anaemia in patients with lower-risk myelodysplastic syndromes with ring sideroblasts who require red blood cell transfusions
Authors: Ghulam J. Mufti , o Ghulam J. Mufti, Paresh Vyas, Rena Buckstein, Valeria Santini, María Díez-Campelo, Carlo Finelli, Osman Ilhan, Mikkael A. Sekeres, Rami S. Komrokji, Amer M. Zeidan, Amit K. Verma, Abderrahmane Laadem, Peter G. Linde, Alan F. List, Uwe Platzbecker, Guillermo Garcia-Manero, Pierre Fenaux
Centre: 


 




PosterSessionOnline
Logo Draft
 
Logo Cert